These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24322736)

  • 1. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients.
    Kim TG; Park W; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Chun HK
    Int J Colorectal Dis; 2014 Feb; 29(2):193-200. PubMed ID: 24322736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
    Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
    Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
    Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
    Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
    Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
    Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.
    Kim TH; Jeong SY; Choi DH; Kim DY; Jung KH; Moon SH; Chang HJ; Lim SB; Choi HS; Park JG
    Ann Surg Oncol; 2008 Mar; 15(3):729-37. PubMed ID: 18057989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of patient subgroups with low risk of postoperative local recurrence for whom total mesorectal excision surgery alone is sufficient: a multicenter retrospective analysis.
    Yamamoto T; Kawada K; Matsusue R; Kato S; Itatani Y; Hida K; Machimoto T; Yamaguchi T; Obama K
    Int J Colorectal Dis; 2022 Oct; 37(10):2207-2218. PubMed ID: 36156129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and failure patterns after chemoradiotherapy for locally advanced rectal cancer with positive lateral pelvic lymph nodes: a propensity score-matched analysis.
    Li S; Song M; Tie J; Zhu X; Zhang Y; Wang H; Geng J; Liu Z; Sui X; Teng H; Cai Y; Li Y; Wang W
    Radiat Oncol; 2024 Oct; 19(1):132. PubMed ID: 39354612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
    Nakanishi R; Akiyoshi T; Toda S; Murakami Y; Taguchi S; Oba K; Hanaoka Y; Nagasaki T; Yamaguchi T; Konishi T; Matoba S; Ueno M; Fukunaga Y; Kuroyanagi H
    Ann Surg Oncol; 2020 Oct; 27(11):4273-4283. PubMed ID: 32767224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
    Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
    J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
    Law BZY; Yusuf Z; Ng YE; Aly EH
    Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
    Kim MJ; Hur BY; Lee ES; Park B; Joo J; Kim MJ; Park SC; Baek JY; Chang HJ; Kim DY; Oh JH
    PLoS One; 2018; 13(4):e0195815. PubMed ID: 29649321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-hoc analysis of clinicopathological factors affecting lateral lymph node metastasis based on STELLAR study for rectal cancer.
    Chen LN; Jiang J; Jiang LM; Zhou HT; Li N; Lu NN; Gao YH; Liu SX; Wang WL; Wei LC; Li S; Cai Y; Li YH; Wang SL; Liu YP; Song YW; Fang H; Chen B; Li YX; Jin J; Tang Y
    Radiother Oncol; 2024 Nov; 200():110512. PubMed ID: 39216825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
    World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node?
    Kim MJ; Chan Park S; Kim TH; Kim DY; Kim SY; Baek JY; Chang HJ; Park JW; Oh JH
    Surgery; 2016 Aug; 160(2):366-76. PubMed ID: 27233638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
    Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
    Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.
    Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    World J Surg; 2017 Mar; 41(3):876-883. PubMed ID: 27730348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.